Treatment and Management of Psoriasis with Nail Involvement: A Focus on Biologic Therapy

被引:41
作者
Langley, Richard G. [1 ]
Dauden, Esteban [2 ]
机构
[1] Dalhousie Univ, Queen Elizabeth II Hlth Sci Ctr, Halifax, NS B3H 2Y9, Canada
[2] Hosp Univ Princesa, Madrid, Spain
关键词
Biologics; Nail disease; Nail psoriasis; Psoriasis; treatment; TO-SEVERE PSORIASIS; TAZAROTENE 0.1-PERCENT GEL; DOUBLE-BLIND; OPEN-LABEL; BETAMETHASONE DIPROPIONATE; CLINICALLY IMPORTANT; STEROID INJECTIONS; INFLIXIMAB; CYCLOSPORINE; ARTHRITIS;
D O I
10.1159/000316179
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Nail involvement in psoriasis is typically overlooked, although it can affect up to 50% of patients with psoriasis and cause functional impact as well as psychological stress that can significantly affect quality of life. In addition, psoriatic patients with nail disease tend to have a more severe skin condition, a higher rate of unremitting and progressive arthritis and more associated anxiety and depression. Historically, the treatment of nail psoriasis has proven difficult, with most patients feeling that the treatment for their nail disease was unsatisfactory. The current management of nail psoriasis includes topical, intralesional and systemic therapies, although little clinical evidence is available on the effectiveness of conventional treatments and, consequently, no specific treatment approach has been fully supported. Biologic agents are beginning to emerge as a viable option to treat patients with both cutaneous and nail clinical manifestations of psoriasis and psoriatic arthritis. The extra disease burden that nail symptoms place on the patient can be considered indicative of a more severe form of the disease and should be taken into consideration when assessing treatment options. Copyright (c) 2010 S. Karger AG, Basel
引用
收藏
页码:29 / 42
页数:14
相关论文
共 75 条
[1]  
*ABB LAB LTD, 2008, HUM PEN SYRING SUMM
[2]  
ABELL E, 1973, BRIT J DERMATOL, V89, P191
[3]   RESPONSE OF NAIL PSORIASIS TO CYCLOSPORINE [J].
ARNOLD, WP ;
GERRITSEN, MJP ;
VANDEKERKHOF, PCM .
BRITISH JOURNAL OF DERMATOLOGY, 1993, 129 (06) :750-751
[4]   Topical treatment of nail psoriasis with a new corticoid-containing nail lacquer formulation [J].
Baran, R ;
Tosti, A .
JOURNAL OF DERMATOLOGICAL TREATMENT, 1999, 10 (03) :201-204
[5]  
Baran R, 1984, DIS NAIL THEIR MANAG
[6]   Remission and time of resolution of nail psoriasis during infliximab therapy [J].
Bianchi, L ;
Bergamin, A ;
de Felice, C ;
Capriotti, E ;
Chimenti, S .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (04) :736-737
[7]   Tazarotene 0.1% gel for psoriasis of the fingernails and toenails: an open, prospective study [J].
Bianchi, L ;
Soda, R ;
Diluvio, L ;
Chimenti, S .
BRITISH JOURNAL OF DERMATOLOGY, 2003, 149 (01) :207-209
[8]   INTRALESIONAL TRIAMCINOLONE ACETONIDE USING PORT-O-JET AND NEEDLE INJECTIONS IN LOCALIZED DERMATOSES [J].
BLEEKER, JJ .
BRITISH JOURNAL OF DERMATOLOGY, 1974, 91 (01) :97-101
[9]   Treatment of psoriatic nails with topical cyclosporin:: A prospective, randomized placebo-controlled study [J].
Cannavò, SP ;
Guarneri, F ;
Vaccaro, M ;
Borgia, F ;
Guarneri, B .
DERMATOLOGY, 2003, 206 (02) :153-156
[10]   Open label trial of alefacept in palmoplantar pustular psoriasis [J].
Carr, David ;
Tusa, Mark G. ;
Carroll, Christie L. ;
Pearce, Daniel J. ;
Camacho, Fabian ;
Kaur, Mandeep ;
Cook, Christina ;
Willard, Joy ;
Mccarty, Ann ;
Fleischer, Alan B., Jr. ;
Liu, Clive M. ;
Goffe, Bernard S. ;
Feldman, Steven R. .
JOURNAL OF DERMATOLOGICAL TREATMENT, 2008, 19 (02) :97-100